In the metastatic patient group, CRELD2 status, CRELD2 expression percentage, body mass index, de novo metastasis, surgery for the primary tumor, Ki-67 level, tumor grade, T stage, and N stage were evaluated as risk factors for OS using univariate Cox regression analysis (Table 4). Here, CRELD2 is linked to neoplasm.